Improves glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this drug should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg.
This drug is generally administered once daily with the evening meal.
The maximum dose of this drug is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg.
Patients with no prior history of diabetes drug treatment who do not achieve adequate glycemic control with monotherapy:
When used as initial therapy in patients with no prior history of diabetes drug treatment, the recommended starting dose of this drug is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin.
For patients switching from combination therapy with dapagliflozin and metformin to this drug, this drug may be initiated at the doses of dapagliflozin and metformin they were previously receiving. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
The safety and efficacy of this drug have not been specifically evaluated in patients switching from other glucose-lowering drugs. Because changes may alter glycemic control, any change in treatment in patients with type 2 diabetes should be made under close monitoring.
This drug should be swallowed whole and must never be crushed, cut, or chewed. Occasionally, the inactive ingredients of this drug may be excreted in the stool as a soft, hydrated mass that resembles a tablet.
Renal impairment
No dose adjustment is necessary in patients with mild renal impairment.
For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or greater and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this drug, is 500mg once daily, and the maximum daily dose is 1000mg.
Administration of this drug is not recommended in patients with an eGFR less than 45 mL/min/1.73m2.
If the estimated glomerular filtration rate (eGFR) decreases to less than 45 mL/min/1.73m2, this drug should be discontinued immediately. Renal function should be evaluated every 3~6 months.
Elderly patients
Because metformin is excreted by the kidneys and renal function is more likely to be decreased in elderly patients, this drug should be used with caution as age increases (see Precautions, 9. Administration to elderly patients).
Improves glycemic control in adults with type 2 diabetes mellitus
Type 2 diabetes with difficult blood sugar control
cardiovascular disease
cardiovascular risk factors
View approved original textHide original text
This medication is used as an adjunct to diet and exercise to assist with blood sugar control in adult patients with type 2 diabetes taking both dapagliflozin and metformin. In patients with type 2 diabetes whose blood sugar is not adequately controlled and who have cardiovascular disease or risk factors, the impact of dapagliflozin on the occurrence of cardiovascular events should be referenced from the professional information. This medication aids in diabetes management and blood sugar improvement to maintain health.
How to take
Adult dose
The dose of this drug should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg.
This drug is generally administered once daily with the evening meal.
The maximum dose of this drug is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg.
Patients with no prior history of diabetes drug treatment who do not achieve adequate glycemic control with monotherapy:
When used as initial therapy in patients with no prior history of diabetes drug treatment, the recommended starting dose of this drug is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin.
For patients switching from combination therapy with dapagliflozin and metformin to this drug, this drug may be initiated at the doses of dapagliflozin and metformin they were previously receiving. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
The safety and efficacy of this drug have not been specifically evaluated in patients switching from other glucose-lowering drugs. Because changes may alter glycemic control, any change in treatment in patients with type 2 diabetes should be made under close monitoring.
This drug should be swallowed whole and must never be crushed, cut, or chewed. Occasionally, the inactive ingredients of this drug may be excreted in the stool as a soft, hydrated mass that resembles a tablet.
Renal impairment
No dose adjustment is necessary in patients with mild renal impairment.
For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or greater and less than 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this drug, is 500mg once daily, and the maximum daily dose is 1000mg.
Administration of this drug is not recommended in patients with an eGFR less than 45 mL/min/1.73m2.
If the estimated glomerular filtration rate (eGFR) decreases to less than 45 mL/min/1.73m2, this drug should be discontinued immediately. Renal function should be evaluated every 3~6 months.
Elderly patients
Because metformin is excreted by the kidneys and renal function is more likely to be decreased in elderly patients, this drug should be used with caution as age increases (see Precautions, 9. Administration to elderly patients).
Precautions
This medication helps in controlling blood sugar levels. However, it can rarely cause a serious condition called lactic acidosis, so caution is advised. When used with other diabetes medications, there may be a risk of hypoglycemia, requiring dosage adjustments.
Patients with impaired kidney function or specific serious diseases, pregnant or breastfeeding women should not use this medication. Furthermore, the medication should be temporarily discontinued during periods of dehydration, severe infection, or unstable physical conditions around surgery.
Regular monitoring of kidney function and fluid status is required while using this medication, especially for elderly patients or those with decreased kidney function. Blood pressure and symptoms should be closely monitored as low blood pressure or dehydration may occur.
Side effects may include genital infections, urinary tract infections, hypoglycemia, dizziness, fluid depletion, etc. If any signs of infection occur, immediate medical attention is needed, and one should also be alert for symptoms of hypoglycemia.
This medication can lower vitamin B12 levels, so checking vitamin B12 concentration is recommended for long-term usage. Alcohol consumption may increase the risk of side effects from this medication, so it should be avoided.
Additionally, this medication can interact with other drugs, so inform your healthcare provider if you are taking any other medications, especially diuretics or blood pressure medications.
Pregnant women or those planning to become pregnant should not use this medication, and breastfeeding women should also avoid its use.
In case of overdose, immediate visit to a medical institution is necessary for appropriate treatment, as this medication is excreted through the kidneys, requiring careful management of kidney function.
While taking this medication, dizziness may occur when driving or operating machinery, so caution is advised, and it should be kept out of reach of children.
Side effects
Severe lactic acidosis
severe hypoglycemia
vulvovaginitis
balanitis
genital infections
urinary tract infections
fungal infections
hypoglycemia
decreased fluid volume
thirst
Show 84 moreCollapse
diabetic ketoacidosis
dizziness
constipation
dry mouth
lower back pain
dysuria
polyuria
nocturia
vulvar itching
genital itching
elevated hematocrit
decreased kidney creatinine clearance
dyslipidemia
elevated serum creatinine
elevated blood urea
weight loss
ketoacidosis
urosepsis
pyelonephritis
acute kidney injury
renal dysfunction
rash
diarrhea
nausea
vomiting
decreased vitamin B12
Guillain-Barré syndrome
bacterial pneumonia
sialadenitis
tendinitis
chest pain
thermal burns
wrist fracture
gastrointestinal stromal tumor
pulmonary malignant neoplasm
uterine fibroids
atrial fibrillation
acute cholecystitis
epigastric pain
dyspepsia
abdominal discomfort
abdominal pain
gastric ulcer
irritable bowel syndrome
salivary gland mass
toothache
headache
facial paralysis
peripheral neuropathy
sensory disturbances
drowsiness
tremor
nasopharyngitis
pharyngitis
adenoviral conjunctivitis
shingles
pneumonia
rhinitis
increased alanine aminotransferase
increased blood sugar
arthralgia
myalgia
myofascial pain syndrome
osteoarthritis
osteochondrosis
limb pain
periarticular inflammation
tendinitis
trigger finger
weakness
fatigue
peripheral edema
edema
pain
vitamin D deficiency
hyperglycemia
urethral syndrome
cough
hyperventilation
itchiness
palpitations
insomnia
Type 2a hyperlipidemia
sensorineural hearing loss
Not everyone experiences these, and they can vary from person to person.
Storage
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. This will help preserve the medication's efficacy.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.